<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="2">35428268</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2334</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC infectious diseases</Title>
          <ISOAbbreviation>BMC Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa.</ArticleTitle>
        <Pagination>
          <StartPage>381</StartPage>
          <MedlinePgn>381</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">381</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-022-07349-8</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Natural immunity against Mycobacterium tuberculosis exists, and &gt; 90% of those infected remain disease-free. Innate and adaptive immune responses required to mediate such protection against tuberculosis (TB) are, however, poorly understood.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This is an analytical study exploring protective and non-protective pathways of immunity against Mycobacterium tuberculosis. Adults without HIV infection are recruited at community healthcare clinics in high TB incidence areas of the Western Cape Province, South Africa. Data regarding participants' medical, social and medication usage will be collected, and clinical examinations and point-of-care tests documented. Reference tests for TB (chest radiographs and sputum tests for GeneXpert MTB/RIF Ultra®, Auramine smear and liquid cultures) and investigations to classify infection states [interferon-gamma release assay (IGRA) and SARS-CoV-2 polymerase chain reaction (PCR) nasopharyngeal swab and IgG], are done on all participants who meet the inclusion criteria. 18F-Fluorodeoxyglucose positron emission tomography combined with computerized tomography will be done on all close contacts (contacts) and healthy control (controls) participants. Participants are divided into 12 study groups representing a spectrum of TB clinical phenotypes and prior SARS-CoV-2 infection based on their TB status, exposure history, results of IGRA test at baseline and 3 months, SARS-CoV-2 serology, and PCR results, and for contacts and controls, PET-CT imaging findings indicative of sub-clinical TB lesions. Samples for experimental assays include whole blood for isolation of peripheral blood mononuclear cells and blood in PAXgene® tubes for RNA isolation. All SARS-CoV-2 PCR negative study participants undergo bronchoscopy for collecting bronchoalveolar lavage samples.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The paired blood and BAL samples will be used for comprehensive analyses of the tissue-specific and systemic immunity that will include e.g., cytometry by time-of-flight analyses, RNA-sequencing, multiplex immunoassays, epigenetic analysis, and mechanistic studies of control of infection by Mycobacterium tuberculosis. Results will be integrated with those from mice and non-human primate studies to provide a comprehensive analysis of protective pathways in natural and vaccine-induced immunity against Mycobacterium tuberculosis.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hiemstra</LastName>
            <ForeName>Andriёtte M</ForeName>
            <Initials>AM</Initials>
            <Identifier Source="ORCID">0000-0002-6331-9858</Identifier>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute Clinical Team, Stellenbosch University, Cape Town, South Africa. ahiemstra@sun.ac.za.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa. ahiemstra@sun.ac.za.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa. ahiemstra@sun.ac.za.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa. ahiemstra@sun.ac.za.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>MacDonald</LastName>
            <ForeName>Candice E</ForeName>
            <Initials>CE</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute Clinical Team, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Rensburg</LastName>
            <ForeName>Ilana C</ForeName>
            <Initials>IC</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute Clinical Team, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stanley</LastName>
            <ForeName>Kim</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute Clinical Team, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maasdorp</LastName>
            <ForeName>Elizna</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Tuberculosis Bioinformatics Initiative, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Bioinformatics and Computational Biology, Stellenbosch University, Stellenbosch, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mc Anda</LastName>
            <ForeName>Shirley</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute Clinical Team, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tönsing</LastName>
            <ForeName>Susanne</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute Clinical Team, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shaw</LastName>
            <ForeName>Jane Alexandra</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute Clinical Team, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tromp</LastName>
            <ForeName>Gerard</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Tuberculosis Bioinformatics Initiative, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Bioinformatics and Computational Biology, Stellenbosch University, Stellenbosch, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van der Spuy</LastName>
            <ForeName>Gian D</ForeName>
            <Initials>GD</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Tuberculosis Bioinformatics Initiative, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Bioinformatics and Computational Biology, Stellenbosch University, Stellenbosch, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Urdahl</LastName>
            <ForeName>Kevin B</ForeName>
            <Initials>KB</Initials>
            <AffiliationInfo>
              <Affiliation>Seattle Children's Research Institute, Seattle, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departments of Pediatrics and Immunology, University of Washington School of Medicine, Washington, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lewinsohn</LastName>
            <ForeName>David M</ForeName>
            <Initials>DM</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health and Science University, Portland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuivaniemi</LastName>
            <ForeName>Helena</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Du Plessis</LastName>
            <ForeName>Nelita</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malherbe</LastName>
            <ForeName>Stephanus T</ForeName>
            <Initials>ST</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute Clinical Team, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Walzl</LastName>
            <ForeName>Gerhard</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Institute Clinical Team, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>South African Tuberculosis Bioinformatics Initiative, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>75N93019C00070</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Infect Dis</MedlineTA>
        <NlmUniqueID>100968551</NlmUniqueID>
        <ISSNLinking>1471-2334</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>63231-63-0</RegistryNumber>
          <NameOfSubstance UI="D012313">RNA</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009169" MajorTopicYN="Y">Mycobacterium tuberculosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000072078" MajorTopicYN="N">Positron Emission Tomography Computed Tomography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013019" MajorTopicYN="N" Type="Geographic">South Africa</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014388" MajorTopicYN="Y">Tuberculosis, Lymph Node</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bronchoalveolar lavage</Keyword>
        <Keyword MajorTopicYN="N">Household contacts</Keyword>
        <Keyword MajorTopicYN="N">Immune response</Keyword>
        <Keyword MajorTopicYN="N">Interferon-gamma release assay</Keyword>
        <Keyword MajorTopicYN="N">PET-CT imaging</Keyword>
        <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        <Keyword MajorTopicYN="N">Tuberculosis</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>16</Day>
          <Hour>5</Hour>
          <Minute>8</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35428268</ArticleId>
        <ArticleId IdType="pmc">PMC9012070</ArticleId>
        <ArticleId IdType="doi">10.1186/s12879-022-07349-8</ArticleId>
        <ArticleId IdType="pii">10.1186/s12879-022-07349-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kasaeva T. WHO global tuberculosis report [Internet]. 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, et al.  Moving toward tuberculosis elimination critical issues for research in diagnostics and therapeutics for tuberculosis infection. Am J Respir Crit Care Med. 2019;199(5):564–571. doi: 10.1164/rccm.201806-1053PP.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201806-1053PP</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen P, Doherty T. The success and failure of BCG—implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005;3(8):656–662. doi: 10.1038/nrmicro1211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro1211</ArticleId>
            <ArticleId IdType="pubmed">16012514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simmons JD, Stein CM, Seshadri C, Campo M, Alter G, Fortune S, et al.  Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat Rev Immunol. 2018;18(9):575–589. doi: 10.1038/s41577-018-0025-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41577-018-0025-3</ArticleId>
            <ArticleId IdType="pmc">PMC6278832</ArticleId>
            <ArticleId IdType="pubmed">29895826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2012;54(6):784–791. doi: 10.1093/cid/cir951.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cir951</ArticleId>
            <ArticleId IdType="pmc">PMC3284215</ArticleId>
            <ArticleId IdType="pubmed">22267721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molton JS, Thomas BA, Pang Y, Khor LK, Hallinan J, Naftalin CM, et al.  Sub-clinical abnormalities detected by PET/MRI in household tuberculosis contacts. BMC Infect Dis. 2019;19(1):1–7. doi: 10.1186/s12879-019-3705-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-019-3705-0</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vanderbilt. REDcap homepage [Internet]. [cited 2021 Sep 7]. Available from: https://www.project-redcap.org/.</Citation>
        </Reference>
        <Reference>
          <Citation>Partridge EF, Bardyn TP. Research electronic data capture (REDCap) J Med Libr Assoc. 2018;106(1):142–144. doi: 10.5195/jmla.2018.319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5195/jmla.2018.319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medicine and Health Sciences Stellenbosch University. Biomedical Research Institute Biorepository Unit [Internet]. Stellenbosch University. 2021 [cited 2021 Jul 9]. p. Biorepository. Available from: http://www.sun.ac.za/english/faculty/healthsciences/biorepository.</Citation>
        </Reference>
        <Reference>
          <Citation>Otterman B. BMRI Research Bronchoscopy Suite unlocks major research opportunities [Internet]. VIVUS. [cited 2021 Sep 7]. Available from: http://www0.sun.ac.za/vivus/vivus-1-march-2021/innovation/bmri-research-bronchoscopy-suite-unlocks-major-research-opportunities.html.</Citation>
        </Reference>
        <Reference>
          <Citation>Young C, Ahlers P, Hiemstra AM, Loxton AG, Gutschmidt A, Malherbe ST, et al.  Performance and immune characteristics of bronchoalveolar lavage by research bronchoscopy in pulmonary tuberculosis and other lung diseases in the Western Cape, South Africa. Transl Med Commun. 2019;4(1):1–12. doi: 10.1186/s41231-019-0039-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s41231-019-0039-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al.  British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults. Thorax. 2013 doi: 10.1136/thoraxjnl-2013-203618.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thoraxjnl-2013-203618</ArticleId>
            <ArticleId IdType="pubmed">23860341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Facciolongo N, Patelli M, Gasparini S, Agli LL, Salio M, Simonassi C, et al.  Incidence of complications in bronchoscopy. Multicentre prospective study of 20,986 bronchoscopies. Monaldi Arch Chest Dis. 2009;71(1):8–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19522159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Fijter JW, Van der Hoeven JG, Eggelmeijer F, Meinders AE. Sepsis syndrome and death after bronchoalveolar lavage. Chest. 1993;104(4):1296–1297. doi: 10.1378/chest.104.4.1296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.104.4.1296</ArticleId>
            <ArticleId IdType="pubmed">8404218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patolia S, Zahir M, Schmidt F, Enriquez D, Quist J, Gulati N, et al.  Bilateral pneumothorax after bronchoscopy without biopsy—a rare complication: case presentation and literature review. J Bronchol Interv Pulmonol. 2012;19(1):57–60. doi: 10.1097/LBR.0b013e3182426243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/LBR.0b013e3182426243</ArticleId>
            <ArticleId IdType="pubmed">23207266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cental Analytical Facilities Stellenbosch University. NuMeRI Node for Infection Imaging—PET-CT Scanner [Internet]. Stellenbosch University. 2021 [cited 2021 Jul 9]. p. Units/Laboratories. Available from: http://www.sun.ac.za/english/faculty/science/CAF/units/pet-ct-scanner.</Citation>
        </Reference>
        <Reference>
          <Citation>European Association of Nuclear Medicine. EARL FDG-PET/CT accreditation programme [Internet]. Research4Life. 2021 [cited 2021 Jul 9]. p. Centres for excellence network. Available from: https://earl.eanm.org/centres-of-excellence-network/.</Citation>
        </Reference>
        <Reference>
          <Citation>Gilbert ES. Ionising radiation and cancer risks: what have we learned from epidemiology? Int J Radiat Biol. 2009;85(6):467–482. doi: 10.1080/09553000902883836.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09553000902883836</ArticleId>
            <ArticleId IdType="pmc">PMC2859619</ArticleId>
            <ArticleId IdType="pubmed">19401906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stellenbosch University Medicine and Health. Biomedical Research Institute Biorepository Unit [Internet]. [cited 2021 Sep 7]. Available from: http://www.sun.ac.za/english/faculty/healthsciences/biorepository.</Citation>
        </Reference>
        <Reference>
          <Citation>Robinson MD, Smyth GK. Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics. 2008;9(2):321–332. doi: 10.1093/biostatistics/kxm030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/biostatistics/kxm030</ArticleId>
            <ArticleId IdType="pubmed">17728317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaipilyawar V, Salgame P. Infection resisters: targets of new research for uncovering natural protective immunity against Mycobacterium tuberculosis. F1000Research. 2019; 8:1–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6774050</ArticleId>
            <ArticleId IdType="pubmed">31602294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection life long? BMJ. 2019;367(October):1–7. doi: 10.1136/bmj.I5770.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.I5770</ArticleId>
            <ArticleId IdType="pmc">PMC6812595</ArticleId>
            <ArticleId IdType="pubmed">31649096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pai M. Spectrum of latent tuberculosis existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol. 2010;8(3):242. doi: 10.1038/nrmicro2236-c1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro2236-c1</ArticleId>
            <ArticleId IdType="pubmed">20084059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Institute of Allergy and Infectious Diseases. ImmPort bioinformatics for the future of immunology [Internet]. [cited 2021 Sep 7]. Available from: https://www.immport.org/home.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
